GOOD
BUSINESS
India pharma market enters US tariff transition with strong domestic growth: Report
Indian Pharmaceutical Market (IPM) posted its strongest monthly performance in more than two years in June, with 16 per cent y-o-y growth, while first-quarter FY27 growth accelerated to 13.5%
Pulse Bharat · Why it matters
Read the original at The Hindu BusinessLine ↗
Strong domestic growth in India's pharmaceutical sector offers economic resilience and potential for increased global market share despite US tariff changes.